FindTrial
Sign In

Treatment of traumatic cerebral hemorrhage with Defetoxamine

Treatment of traumatic cerebral hemorrhage with Defetoxamine

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-16008517
Enrollment
Unknown
Registered
2016-05-22
Start date
2016-06-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Traumatic brain injury

Interventions

Intervention group:Use Defetoxamine
Control:No Defetoxamine

Sponsors

Huashan Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) over 18 years old; (2) patients with traumatic intracranial hemorrhage; (3) supratentorial hemorrhage; (4) bleeding capacity 10-30ml; (5) bleeding within 8 hours before admission.

Exclusion criteria

Exclusion criteria: (1) Traumatic hemorrhage; (2) hemorrhage due to AVM, aneurysm or tumor; (3) unable to undergo MR exam; (4) Used to receive Defetoxamine therapy; (5) Renal function comprimised (Cr over 2mg/dl); (6) Iron-deficiency anemia; (7) indication for surgery; (8) Heart function comprimised; (9) pregnent; (10) expected survival less than 90 days.

Design outcomes

Primary

MeasureTime frame
decrease of hemorrhage volume;—

Secondary

MeasureTime frame
GOS;Plasma ferritin, transferrin;—

Countries

China

Contacts

Public ContactJian Yu

Huashan Hospital, Fudan University

15197533@qq.com+86 13918076825

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026